News

Advocates call for action to tackle damaging delays in myeloma diagnosis

Over one-third of European myeloma patients experience delays in diagnosis. ‘Myeloma Diagnosis Across Europe’, a pan-European survey and focus groups report published on European Myeloma Day (September 27th), revealed a landscape where…

News

Hope on horizon for blood test detecting unscreenable cancers

Multi-cancer early detection (MCED) tests offer a feasible approach for detecting 36 different types of cancer, over two thirds of which have no screening tests available. The PATHFINDER study, reported at the…

News

NSCLC and climate change share common cause in particulate matter

Particles found in vehicle exhaust and combustion of fossil fuels are associated with non-small cell lung cancer (NSCLC) risk. A study presented in the Presidential Symposium at the European Society for Medical Oncology…

News

UK consensus group calls for biomarker testing at point of diagnosis

All cancer patients should be offered genomic profiling of their tumours at the point of diagnosis and during treatment to shape care and track how their disease evolves and responds to treatment.…

News

Frequent aspirin use associated with ovarian cancer risk-reduction

Frequent aspirin (acetyl salicyclic acid) use is associated with lower ovarian cancer risk regardless of the presence of most ovarian cancer risk factors. The meta-analysis of data from two ovarian cancer consortia,…

News

Resistant starch equivalent to eating a daily banana cuts hereditary cancer risk

Consuming resistant starch (RS), also known as fermentable fibre, reduces the risk of non-colorectal cancers (non-CRCs) by nearly 50% in people with Lynch syndrome. The study, published in Cancer Prevention Research, 25…

News

Abnormal collagen provides ‘invisibility cloak’ in pancreatic cancer offering new therapeutic targets

Cancer cells produce an atypical collagen in pancreatic cancer creating an extracellular matrix that influences the tumour microbiome to protect against immune responses. The study, published in Cancer Cell, July 21, suggests…

News

Study paves way for better checkpoint inhibitor response prognostication

Use of whole exome sequencing improves prediction of response to immune checkpoint blockade (ICB). The study, published in Nature Communications, 8 July, shows incorporation of the CIRCLE tool, including new genes and…

News

Pancreatic cancer patients diagnosed early through screening achieve long-term survival

The majority of high-risk patients diagnosed with pancreatic ductal adenocarcinoma (PDAC) while enrolled in a screening programme have stage I disease and can achieve long-term survival. The study, published in Journal of…

News

Study defines increased risk of cardiovascular disease among cancer survivors

Adult survivors of cancer have a 37% higher risk of developing cardiovascular disease (CVD) than people without cancer. The study, published in the Journal of the American College of Cardiology, July 5…